Bioactivity:

Darotropium bromide(GSK233705, GSK233705B) is an inhaled long-acting muscarinic antagonist under development for the treatment of chronic obstructive pulmonary disease (COPD).GSK233705 showed bronchiectasis activity and was well tolerated.

CAS nr:

850607-58-8

Purity:

98%

Molecular Weight:

425,41

SMILES:

C[N+]1(C)[C@@]2([H])CC(CC(C3=CC=CC=C3)(C#N)C4=CC=CC=C4)C[C@@]1([H])CC2.[Br-]

Formula:

C24H29BrN2

Pathway:

Target: